CTRB1 and ABO were associated with risk of pancreatic cancer of which one was only associated with pancreas cancer and largely only expressed in the exocrine pancreas, CTRB1 [OR: 0.79, 95% CI: 0.73 to 0.85; PP4: 0.99]. This evidence concerns the gene CTRB1 and pancreatic neoplasm.